Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phathom Pharmaceuticals

4.03
-0.1950-4.62%
Post-market: 4.030.00000.00%19:40 EDT
Volume:956.15K
Turnover:3.94M
Market Cap:275.56M
PE:-0.76
High:4.30
Open:4.30
Low:4.02
Close:4.23
Loading ...
Apr 16, 2025

Major Issues Report

Form 8-K - Current report
Apr 03, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 06, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 06, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Aug 22, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 19, 2024

Major Issues Report

Form 8-K - Current report
Aug 19, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jul 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 15, 2024

Correspondence

Form CORRESP - Correspondence
Jun 14, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Jun 14, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Jun 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 24, 2024

Major Issues Report

Form 8-K - Current report